Cerebrospinal Fluid Biomarkers of Alzheimer Disease
Alzheimer disease (AD) is a chronic neurodegenerative disorder and the most common cause of dementia in the elderly. Current international guidelines for the clinical diagnosis of AD consider the diagnosis to be both clinical and biological. It requires a specific clinical phenotype and a confirmed...
Saved in:
| Main Authors: | Kseniya V. Nevzorova, Yuliya A. Shpilyukova, Аlla A. Shabalina, Ekaterina Yu. Fedotova, Sergey N. Illarioshkin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Research Center of Neurology
2025-06-01
|
| Series: | Анналы клинической и экспериментальной неврологии |
| Subjects: | |
| Online Access: | https://annaly-nevrologii.com/pathID/article/viewFile/1185/pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Machine-learning based strategy identifies a robust protein biomarker panel for Alzheimer’s disease in cerebrospinal fluid
by: Xiaosen Hou, et al.
Published: (2025-07-01) -
Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
by: Sebastian Palmqvist, et al.
Published: (2019-11-01) -
Associations between platelet indices and cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact adults: the CABLE study
by: Shi-Yin Xiong, et al.
Published: (2025-05-01) -
Cerebrospinal fluid levels of tumour necrosis factor-α and its receptors are not associated with disease progression in Alzheimer’s disease
by: Manal Aljuhani
Published: (2025-04-01) -
Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer’s disease patients
by: Matthew Paul Lennol, et al.
Published: (2022-11-01)